D-0326-2022 Class III Terminated

Recalled by Lupin Pharmaceuticals Inc. — Baltimore, MD

Recall Details

Product Type
Drugs
Report Date
January 12, 2022
Initiation Date
December 22, 2021
Termination Date
September 12, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
50,832 bottles

Product Description

Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-435-01.

Reason for Recall

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Distribution Pattern

Nationwide in the USA and Puerto Rico

Code Information

Lot #: H003037, exp. date May 2022; H100132, exp. date June 2022; H100847, exp. date October 2022